Cargando…

Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma

BACKGROUND: Survivin is a small protein inhibitor of apoptosis and a tumor associated antigen. Survivin expression in multiple myeloma is associated with poor prognosis, disease progression, and drug resistance. The CD4+ response against survivin remains uncharacterized. METHODS: In order to better...

Descripción completa

Detalles Bibliográficos
Autores principales: Locke, Frederick L, Menges, Meghan, Veerapathran, Anandharaman, Coppola, Domenico, Gabrilovich, Dmitry, Anasetti, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437443/
https://www.ncbi.nlm.nih.gov/pubmed/25992291
http://dx.doi.org/10.1186/s40425-015-0065-1

Ejemplares similares